Jazz/Solvay Gain Approval Of Luvox CR
This article was originally published in The Pink Sheet Daily
Executive Summary
Approval of anxiety/obsessive compulsive disorder drug comes a day ahead of its scheduled user fee date.
You may also be interested in...
Jazz Delays Trials, Reduces Staff
Late-stage trials wait until 2009 as firm "leans in partnering direction," chairman tells "The Pink Sheet" DAILY.
Jazz Delays Trials, Reduces Staff
Late-stage trials wait until 2009 as firm "leans in partnering direction," chairman tells "The Pink Sheet" DAILY.
Jazz Pharmaceuticals’ Luvox CR Gets Feb. 29 Action Date
Company expects to launch the extended-release anti-anxiety medication in the first quarter, after FDA accepts response to “approvable” letter.